Advertisement

Journal of Gastrointestinal Cancer

, Volume 50, Issue 4, pp 967–971 | Cite as

“Pure” High-Grade Large Cell Neuroendocrine Carcinoma Arising from Low- and High-Grade Dysplasia of the Gallbladder: Case Report and Review of the Literature

  • Cacey Peters
  • Eleanor Lewin
  • Tong Wu
  • Yukihiro NakanishiEmail author
Case Report
  • 36 Downloads

Introduction

Neuroendocrine neoplasms of the gallbladder are classified as grades 1 and 2 neuroendocrine tumors, neuroendocrine carcinoma (NEC) (large cell (LCNEC) or small cell type (SCNEC)), and mixed adenoneuroendocrine carcinoma (MANEC) [1]. NEC of the gallbladder is rare, comprising 0.5% of all neuroendocrine tumors and 2.1% of all gallbladder cancers [2]. In most cases of NEC of the gallbladder, the histological components include adenocarcinoma [3, 4, 5]. Among the reported cases of NEC of the gallbladder, only seven reported cases were “pure” LCNEC without adenocarcinoma component [3, 6, 7, 8, 9, 10]. The origin of such tumors has been debated, with varying support for each theory. The primary concepts consist of the malignant transformation of neuroendocrine cells derived from multipotent stem cell within the gallbladder or the malignant transformation of neuroendocrine cells in metaplastic intestinal or gastric mucosa secondary to chronic inflammation [3, 5].

We here report,...

Notes

Compliance with Ethical Standards

Conflict of Interests

The authors have no conflict of interests.

References

  1. 1.
    Komminoth P, Arnold R, Capella C et al. Neuroendocrine neoplasms of the gallbladder and extrahepatic bile ducts. In: Bosman FT, Carneiro F, Hruban RH, Theise HD, editors. World Health Organization Classification of Tumours of the Digestive System. Fourth edition. World Health Organization Classification of Tumours. Lyon: International Agency for Research on Cancer; 2010, p. 274–276.Google Scholar
  2. 2.
    Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, et al. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008;26:3063–72.CrossRefGoogle Scholar
  3. 3.
    Papotti M, Cassoni P, Sapino A, Passarino G, Krueger JE, Albores-Saavedra J. Large cell neuroendocrine carcinoma of the gallbladder: report of two cases. Am J Surg Pathol. 2000;24:1424–8.CrossRefGoogle Scholar
  4. 4.
    Sato K, Imai T, Shirota Y, Ueda Y, Katsuda S. Combined large cell neuroendocrine carcinoma and adenocarcinoma of the gallbladder. Pathol Res Pract. 2010;206:397–400.CrossRefGoogle Scholar
  5. 5.
    Mondolfi AEP, Slova D, Fan W, Attiyeh FF, Afthinos J, Reidy J, et al. Mixed adenoneuroendocrine carcinoma (MANEC) of the gallbladder: a possible stem cell tumor? Pathol Int. 2011;61:608–14.CrossRefGoogle Scholar
  6. 6.
    Jun SR, Lee JM, Han JK, Choi BI. High-grade neuroendocrine carcinomas of the gallbladder and bile duct. Report of four cases with pathological correlation. J Comput Assist Tomogr. 2006;30:604–9.CrossRefGoogle Scholar
  7. 7.
    Iype S, Mirza TA, Propper DJ, Bhattacharya S, Feakins RM, Kocher HM. Neuroendocrine tumours of the gallbladder: three cases and a review of the literature. Postgrad Med J. 2009;85:213–8.CrossRefGoogle Scholar
  8. 8.
    Shimono C, Suwa K, Sato M, Shirai S, Yamada K, Nakamura Y, et al. Large cell neuroendocrine carcinoma of the gallbladder: long survival achieved by multimodal treatment. Int J Clin Oncol. 2009;14:351–5.CrossRefGoogle Scholar
  9. 9.
    Okuyama Y, Fukui A, Enoki Y, Morishita H, Yoshida N, Fujimoto S. A large cell neuroendocrine carcinoma of the gallbladder: diagnosis with 18 FDGPET/CT-guided biliary cytology and treatment with combined chemotherapy achieved a long-term stable condition. Jpn J Clin Oncol. 2013;43:571–4.CrossRefGoogle Scholar
  10. 10.
    Buscemi S, Orlando E, Damiano G, et al. “Pure” large cell neuroendocrine carcinoma of the gallbladder. Report of a case and review of the literature. Int J Surg. 2016: S128–S132.CrossRefGoogle Scholar
  11. 11.
    Travis WD, Linnoila RI, Tsokos MG, Hitchcock CL, Cutler GB, Nieman L, et al. Neuroendocrine tumors of the lung with proposed criteria for large cell neuroendocrine carcinoma. An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases. Am J Surg Pathol. 1991;15:529–53.CrossRefGoogle Scholar
  12. 12.
    Gilks BC, Young RH, Gersell DJ, et al. Large cell carcinoma of the uterine cervix: a clinicopathologic study of 12 cases. Am J Surg Pathol. 1997;21:905–14.CrossRefGoogle Scholar
  13. 13.
    Larsson LG, Donmer LR. Large cell neuroendocrine carcinoma of the parotid gland: fine needle aspiration, light microscopic and ultrastructural study. Acta Cytol. 1999;43:534–6.PubMedGoogle Scholar
  14. 14.
    Agoff SN, Lamps LW, Philip AT, Amin MB, Schmidt RA, True LD, et al. Thyroid transcription factor-1 is expressed in extrapulmonary small cell carcinomas but not in other extrapulmonary neuroendocrine tumors. Mod Pathol. 2000;13:238–42.CrossRefGoogle Scholar
  15. 15.
    Duval JV, Savas L, Banner BF, et al. Expression of cytokeratin 7 and 20 in carcinomas of the extrahepatic biliary tract, pancreas, and gallbladder. Arch Pathol lab Med. 2000;124:1196–2000.PubMedGoogle Scholar
  16. 16.
    Wu X, Akiyama Y, Igari T, et al. Expression of homeodomain protein CDX2 in gallbladder carcinomas. J Cancer Res Clin Oncol. 2005;131:271–8.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Cacey Peters
    • 1
  • Eleanor Lewin
    • 1
  • Tong Wu
    • 1
  • Yukihiro Nakanishi
    • 1
    Email author
  1. 1.Department of PathologyTulane University School of MedicineNew OrleansUSA

Personalised recommendations